Supply Chain Intelligence

Corbus Pharmaceuticals Holdings, Inc. Supply Chain

CRBP supply chain intelligence for Corbus Pharmaceuticals Holdings, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

CRBP ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
1Customers
3Debt Items
20Related Chains

Corbus Pharmaceuticals Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
CSPC CSPC 90% We are a party to a license agreement with CSPC pursuant to which we licensed the exclusive rights in the U.S., Canada, the European Union (including the European Free Trade Area), the U.K., and Aust…
CSPC-MEGALITH-BIOPHARMACEUTICAL-CO-LTD CSPC-MEGALITH-BIOPHARMACEUTICAL-CO-LTD 90% The Company paid CSPC an upfront payment of $ 7.5 million
THE-REGENTS THE-REGENTS 90% The Company paid The Regents a license issue fee of $ 1.5 million
JENRIN JENRIN 85% The Company is obligated to pay Jenrin up to $ 18.0 million in additional potential milestone payments
PLRX Pliant Therapeutics, Inc. 72% Reciprocal relationship from PLRX graph: duct candidates and jeopardize our ability to commercialize our product candidates and generate revenue. 32 In addition, there are risks associated with large…

Corbus Pharmaceuticals Holdings, Inc. Customers

TickerNameConfidenceEvidence
PLRX Pliant Therapeutics, Inc. 72% Reciprocal relationship from PLRX graph: Reciprocal relationship from CRBP graph: Reciprocal relationship from PLRX graph: Reciprocal relationship from CRBP graph: Reciprocal relationship from PLRX g…

Corbus Pharmaceuticals Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CRBP-DEBT-8833 Warrants outstanding: 2873 90% xbrl warrant detail from xbrl 2025-12-31.
CRBP-DEBT-8834 Xbrl Convertible 90% xbrl convertible detail from xbrl 2014-12-31.
CRBP-DEBT Debt stack $1.2M 90% Market cache reports total debt of $1.2M.

Corbus Pharmaceuticals Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Corbus Pharmaceuticals Holdings, Inc..

Corbus Pharmaceuticals Holdings, Inc. Ownership

HolderNameConfidenceEvidence
CRBP-OWNER-CORMORANT-ASSET-MANAGEMENT-LP Cormorant Asset Management, LP 90% 13F overlay lists Cormorant Asset Management, LP as top holder; 107 tracked holders.

Corbus Pharmaceuticals Holdings, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EVAX Evaxion A/S 100.00 2
GHRS GH Research PLC 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
BOLT Bolt Biotherapeutics, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
GMAB Genmab A/S 100.00 2
CPMV Mosaic ImmunoEngineering, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
LGND Ligand Pharmaceuticals Incorporated 100.00 2
HTGC Hercules Capital, Inc. 100.00 2
DEO Diageo plc 100.00 2
CCCC C4 Therapeutics, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
CANF Can-Fite BioPharma Ltd. 100.00 2
GPCR Structure Therapeutics Inc. 100.00 1 ['receiving']
View CRBP supply chain intel →

Explore the full interactive supply chain map for Corbus Pharmaceuticals Holdings, Inc..

Open CRBP supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map